Adtalem Global Education (NYSE:CVSA) SVP Douglas Beck Sells 2,439 Shares

Posted by Brenda Bartman on Jul 10th, 2026

Adtalem Global Education Inc. (NYSE:CVSA – Get Free Report) SVP Douglas Beck sold 2,439 shares of the company’s stock in a transaction on Wednesday, July 8th. The stock was sold at an average price of $135.34, for a total value of $330,094.26. Following the transaction, the senior vice president directly owned 33,070 shares in the company, valued at $4,475,693.80. This represents a 6.87% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Performance

NYSE:CVSA opened at $131.17 on Friday. Adtalem Global Education Inc. has a 1 year low of $86.97 and a 1 year high of $156.26. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.70 and a quick ratio of 0.70. The business has a fifty day simple moving average of $124.40. The stock has a market capitalization of $4.46 billion, a PE ratio of 20.43, a price-to-earnings-growth ratio of 0.99 and a beta of 0.62.

Adtalem Global Education (NYSE:CVSA – Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported $1.98 EPS for the quarter, topping the consensus estimate of $1.73 by $0.25. The company had revenue of $487.03 million for the quarter. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. Adtalem Global Education’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.92 earnings per share. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. On average, analysts predict that Adtalem Global Education Inc. will post 8.04 EPS for the current year.

Analyst Ratings Changes

CVSA has been the subject of a number of research analyst reports. Zacks Research cut shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 25th. Barrington Research restated an “outperform” rating and issued a $170.00 price target on shares of Adtalem Global Education in a report on Monday, June 8th. Truist Financial raised their price objective on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Wall Street Zen raised Adtalem Global Education from a “hold” rating to a “buy” rating in a report on Saturday, June 13th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Friday, May 22nd. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $155.00.

View Our Latest Report on Adtalem Global Education

About Adtalem Global Education

(Get Free Report)

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.